Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9448159rdf:typepubmed:Citationlld:pubmed
pubmed-article:9448159lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0376387lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0520463lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0449259lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0035015lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0279030lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C1882923lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C1548437lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:9448159lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:9448159pubmed:issue1lld:pubmed
pubmed-article:9448159pubmed:dateCreated1998-2-11lld:pubmed
pubmed-article:9448159pubmed:abstractTextThe influence of hepatitis C virus (HCV) infection has been discussed in kidney transplantation. Our case study focused on four points: the clinical course of an HCV-infected recipient; the pathogenesis of hepatic disorders in such a patient; interferon (IFN)-alpha therapy; and the risk of IFN-alpha therapy.lld:pubmed
pubmed-article:9448159pubmed:languageenglld:pubmed
pubmed-article:9448159pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448159pubmed:citationSubsetIMlld:pubmed
pubmed-article:9448159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448159pubmed:statusMEDLINElld:pubmed
pubmed-article:9448159pubmed:monthJanlld:pubmed
pubmed-article:9448159pubmed:issn0041-1337lld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:IchikawaYYlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:NaganoSSlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:KishikawaHHlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:HanafusaTTlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:FukunishiTTlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:ShinjiYYlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:KyoMMlld:pubmed
pubmed-article:9448159pubmed:authorpubmed-author:KohroTTlld:pubmed
pubmed-article:9448159pubmed:issnTypePrintlld:pubmed
pubmed-article:9448159pubmed:day15lld:pubmed
pubmed-article:9448159pubmed:volume65lld:pubmed
pubmed-article:9448159pubmed:ownerNLMlld:pubmed
pubmed-article:9448159pubmed:authorsCompleteYlld:pubmed
pubmed-article:9448159pubmed:pagination134-8lld:pubmed
pubmed-article:9448159pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:meshHeadingpubmed-meshheading:9448159-...lld:pubmed
pubmed-article:9448159pubmed:year1998lld:pubmed
pubmed-article:9448159pubmed:articleTitleA 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy.lld:pubmed
pubmed-article:9448159pubmed:affiliationDepartment of Urology, Kidney Transplant Center, Hyogo Prefectural Nishinomiya Hospital, Japan.lld:pubmed
pubmed-article:9448159pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9448159pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9448159lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9448159lld:pubmed